Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

YTTERBIUM YB 169 DTPA

PENTETATE CALCIUM TRISODIUM YB-169

Standard Dose
2mCi/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview YTTERBIUM YB 169 DTPA is listed in Drugs@FDA under application 017518 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient PENTETATE CALCIUM TRISODIUM YB-169 Form and strength INJECTABLE;INJECTION - 2mCi/ML Sponsor 3M Submission history Latest submission status date: 1985-03-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview YTTERBIUM YB 169 DTPA is listed in Drugs@FDA under application 017518 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient PENTETATE CALCIUM TRISODIUM YB-169 Form and strength INJECTABLE;INJECTION - 2mCi/ML Sponsor 3M Submission history Latest submission status date: 1985-03-05 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.